http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MA-39693-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
filingDate 2016-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a783993c783a8fa038d5f15eda0125be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be9d6c08dc0056a075bd7ee21b18b404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62bcd9fdd4cfde75dbc43bbce0f84227
publicationDate 2018-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MA-39693-B1
titleOfInvention Association of 3 - [(3 - {[4- (4-morpholinylmethyl) -1H-pyrrol-2-yl] methylene} -2-oxo-2,3-dihydro-1H-indol-5-yl) methyl] -1,3-thiazolidine-2,4-dione and an inhibitor of tyr kinase of egfr
abstract Association of 3 - [(3 - {[4- (4-morpholinylmethyl) -1H-pyrrol-2-yl] methylene} -2-oxo-2,3-dihydro-1H-indol-5-yl methyl] -1,3-thiazolidine-2,4-dione of formula (i): or one of its z or e isomers and / or addition salts with a pharmaceutically acceptable acid or base, and a tyrosine inhibitor human epidermal growth factor receptor (EGFR) kinase, and its use in the treatment of non-small cell lung cancer.
priorityDate 2015-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393818
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421614372
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID378478
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404306
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1956
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396494
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37455
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID463415
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484026
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421311760
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID407217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75311185
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04412

Total number of triples: 43.